FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"\n\n\n\nFSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, May 20, 2019\n\n\n\nDaniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA Join distinguished group of Scientific Advisors\n TORONTO, May 20, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (\"FSD\" or the \"Company\"), is pleased to announce that three eminent cannabis researchers have joined the company's Scientific Advisory Board (\"SAB\").\n\n \n \n\n \n\"We are honored to welcome Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA to our Scientific Advisory Board,\" said Dr. Raza Bokhari, FSD Executive Co-Chairman & Chief Executive Officer. \"This trio of world-renowned experts will play a key role in our company's scientific and clinical development programs. Their guidance will be invaluable in shaping the biopharmaceutical strategic direction of the company.\"\nThe new members include:\nDaniel Piomelli, Ph.D.\nDr. Piomelli is the Louise Turner Arnold Chair in Neurosciences and Distinguished Professor of Anatomy and Neurobiology, Pharmacology and Biological Chemistry at the University of California, Irvine, where he is also the Director of the Center for the Study of Cannabis. He has authored more than 400 peer-reviewed articles in high-impact journals, three full-length books and 34 patents and founded the Department of Drug Discovery and Development at the Italian Institute of Technology in Genoa, Italy, which he directed from 2007 to 2016. He is Editor-in-Chief of Cannabis and Cannabinoid Research, the only peer-reviewed journal entirely dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system.\nRyan Vandrey, Ph.D.\nDr. Vandrey is an experimental psychologist and an Associate Professor at the Behavioral Pharmacology Research Unit at Johns Hopkins University. Dr. Vandrey's research focuses pr...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B